This study investigates the effects of alternating chemotherapy treatments on borderline resectable pancreatic cancer. The purpose of this study is to understand more about how these treatments work for this condition.
The study evaluates the safety and effectiveness of using two different chemotherapy treatments in sequence. It checks how well these treatments work and how safe they are for patients.
- Who can participate: Adults aged 18 and older with borderline resectable pancreatic cancer can join. Participants must be able to provide informed consent.
- Study details: Participants will receive alternating chemotherapy treatments. A placebo will not be used in this study.